Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Nantahala Capital Management

Tracked across 4 events · 25 articles · First seen Apr 14, 2026 · Last active Sep 18, 2026

Sentiment
12
Attention
4
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 20
Business
Impact: Nantahala Capital Management led the private placement as the new institutional investor, demonstrating confidence in Femasys' strategy and technologies.
Aug 07, 2026 · 6 articles
2 10
Business
Lisata Therapeutics acquired Marea Therapeutics, a clinical-stage biotechnology company developing next-generation medicines for cardioendocrine diseases, in a stock-for-stock transaction. All of Marea's outstanding equity interests were exchanged for 1,793,129 shares of Lisata common stock and…
Impact: Participated in the oversubscribed private placement financing.
Sep 17, 2026 · 6 articles
4 10
Business
Impact: Nantahala Capital Management is one of the new investors participating in the $350 million private placement financing for the combined Galera Therapeutics and Obsidian Therapeutics, Inc. entity.
Apr 14, 2026 · 7 articles
2 10
Business
Impact: Nantahala Capital Management is a participating investor in the private placement, providing capital to Quoin Pharmaceuticals.
Aug 28, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Nantahala Capital Management live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.